Skip to content
BetBrit Online

Zimbabwe Declines ‘Lopsided’ American Healthcare Assistance Package Over Information Apprehensions

Health funding illustration
The proposed US funding was aimed at programmes for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

Zimbabwe has rejected a significant American healthcare agreement worth $367m (272 million pounds) spanning five years over Washington's request for confidential biological samples.

This rejection came to light after a official document dated December was leaked, indicating that President Emmerson Mnangagwa felt the agreement was "lopsided".

A government representative later stated that the US was seeking health data for research and profit while was not willing to share the resulting advantages from future medical innovations.

"We must now begin the challenging and unfortunate task of scaling back our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy indicated the US had furnished more than $1.9bn as health assistance to Zimbabwe during the past twenty years.

A doctors' association in Zimbabwe has called for further negotiations to secure a deal agreeable to both sides so the country's critical HIV treatment initiative can be sustained.

Broader Background

This rejection follows a comparable case in neighbouring Kenya, where a high court suspended a similar deal with the US after concerns were filed about the security of Kenyans' health data.

Since returning to the presidency recently, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).

The agency had managed assistance for the American government, but Trump claimed its spending was "inefficient" and his government was pursuing direct bilateral deals to boost openness and responsibility.

As per reports, Sixteen African countries have so far signed these new agreements, representing more than $18.3bn in committed funds.

Specifics of the Rejected Deal

The funds for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this cooperation would have delivered significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently receiving HIV treatment via US-supported programmes," the Ambassador added.

However, official spokesman Nick Mangwana argued the proposed deal was "unfair".

"Zimbabwe was being asked to surrender its genetic material and health information indefinitely, without any corresponding guarantee of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.

"In essence, our country would provide the raw materials for scientific discovery with no assurance that the resulting innovations would be accessible to our population if a future pandemic emerge."

National Interest and International Frameworks

Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were undermining systems already set up through the international health agency.

The spokesperson cited its Pandemic Benefit-Sharing scheme created to deal with future pandemics.

"This framework is intended to guarantee that when a country contributes its data, the benefits – including medicines and cures – are distributed fairly, not commercialised solely by those with the resources to develop them."

Zimbabwe's reservations over the US deal "should not be misconstrued as opposition to America," he added.

"We welcome continued dialogue with our American counterparts on how future collaboration could be designed in a manner that honours the sovereignty and interests of both nations."

Health Experts Reaction

Medical experts expressed it understood the official position, but recommended that negotiations need to persist given that a large portion of the nation's Aids initiatives were funded by foreign aid.

"Where technical issues exist, such as those involving information security or agreement terms, these can frequently be addressed via detailed discussion and negotiated safeguards," the group commented.

This impasse highlights the continuing challenges between accepting much-needed foreign assistance and safeguarding local interests in an increasingly data-driven world.

Written by

Karen Mckee

A seasoned sports analyst with over a decade of experience in UK betting markets, specializing in football and horse racing.

BetBrit Online

Type to search articles.